ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0704

Clinical Characteristics and Outcomes in Patients Found to Have Clinically Isolated Aortitis After Aortic Aneurysm Repair: A Single-Center Experience

Ora Gewurz-Singer1, Julia Ford2, Thu Thu Aung2 and Lauren Humphrey-Stark2, 1University of Michigan, Huntington Woods, MI, 2University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2023

Keywords: Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0691–0721) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Clinically isolated aortitis (CIA), or aortitis in the absence of identifiable systemic vasculitis, is typically discovered histopathologically after aortic aneurysm repair. The approach to caring for CIA patients as a rheumatologist remains uncertain, including the role of immunosuppression (IS) and the risk of developing systemic rheumatologic disease. To add to the limited literature on this topic1,2,we conducted a study using the Cardiovascular Health Improvement Project (CHIP) database at Michigan Medicine, which is enriched for patients with surgical aortic disease. Our aim was to identify and describe CIA patients in CHIP and provide insights into the clinical characteristics and outcomes.

Methods: We queried CHIP to identify patients with diagnosis codes or keywords in the electronic medical record (EMR) related to aortitis from 8/1/2013-3/31/2022. CIA cases were independently verified with chart review by two physicians. Patients without any follow-up in the EMR after diagnosis of aortitis were excluded. Clinical data was recorded at time of CIA diagnosis until date of last follow-up in EMR, including subsequent aortic events (subsequent aortic surgery, new or worsening aneurysm, new stenosis, or dissection).

Results: 17 patients with CIA were identified with 7.1 (IQR 2.9, 10.0) years of follow-up, all of whom had undergone ascending aortic aneurysm repair. Clinical characteristics at CIA diagnosis are presented in Table 1. Rheumatology was engaged post-operatively in 10 cases (59%); only 3 patients (18%) were treated with IS (steroids ± tocilizumab) at any point during follow-up. One patient was diagnosed with systemic rheumatologic disease (rheumatoid arthritis) 6.6 years after CIA diagnosis. Subsequent aortic events occurred in 5 patients (29%) at median 3.7 (IQR 1.5, 6.2) years of follow-up (Figure 1). One patient passed due to unrelated reasons 16.4 years after CIA diagnosis.

Conclusion: In this single-center cohort of 17 patients with CIA aortic aneurysm repair, there was a high prevalence of hypertension and ever-smoking, and post-operative inflammatory markers (when available) tended to be normal. Interestingly, evolution into systemic rheumatologic disease was uncommon. A third of patients had subsequent aortic events after CIA diagnosis, highlighting the need for continued clinical surveillance of patients with CIA; no conclusions could be drawn regarding the impact of IS on preventing subsequent aortic events.

References:
1. Mayer A, Sperry A, Quimson L, Rhee R. Long-term clinical and radiographic outcomes in patients with clinically isolated aortitis. ACR Open 2022 Dec;4(12):1013-1020.
2. Clifford A, Arafat A, Idrees J et al. Outcomes among 196 patients with noninfectious proximal aortitis. Arth Rheum 2019 71(12):2112:2120.

Supporting image 1

Supporting image 2


Disclosures: O. Gewurz-Singer: None; J. Ford: None; T. Aung: None; L. Humphrey-Stark: None.

To cite this abstract in AMA style:

Gewurz-Singer O, Ford J, Aung T, Humphrey-Stark L. Clinical Characteristics and Outcomes in Patients Found to Have Clinically Isolated Aortitis After Aortic Aneurysm Repair: A Single-Center Experience [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/clinical-characteristics-and-outcomes-in-patients-found-to-have-clinically-isolated-aortitis-after-aortic-aneurysm-repair-a-single-center-experience/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-and-outcomes-in-patients-found-to-have-clinically-isolated-aortitis-after-aortic-aneurysm-repair-a-single-center-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology